Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
Games developer tinyBuild seeks to boost £500 million market cap by becoming a media company. Watch the full video here.
Posted in: 0FGH
nearly killed me, 60% wipe out in 2 weeks, CHRIST ALIVE!
Posted in: SNG
Thats rights livlif, I remember seeing interferons mentioned in scripture for the battle of Hastings 1066 ;)
This share is like riding a bucking bronco
Yes, the exact same definition is given to Synairgen/ Clinergens Managed Access Programme (MAP) launched in OCT 2020.Wouldn't get too excited just yet.
Posted in: TERN
I only bought in on Monday after seeing some 'noise' on other chat rooms, SP up 100% in a week. Excellent!
*'..the injected or infused agents are being reserved for the more seriously ill patients.'
unfortunately Doc, we already know we are not getting the more seriously ill patients on our P2 ACTIV-2, the panellist told us that in the interview. 'Interferon-Beta is being used on mild outpatient cases, the seriously ill patients are being reserved for the injected or infused agents'hTTps://www.facebook.com/kuhospital/videos/1116924078826762/
I'm not convinced a British product we will be included in the EU priority list, especially given their frustration with AZ on the vaccine production side and Brexit. They would be more likely to take up the French interferon trial than ours. IMO
what was your question to them Mrcosts?
Scinv, I for one have always valued your academic input here, and would respectfully ask you to keep posting.
Look at the same websites data set presented in a different format Fruitsneg and you get an better visual of the current situation in SA. Very low COVID numbers, thus very low trial patient numbers for clinical trials. https://www.statista.com/statistics/1107993/coronavirus-cases-in-south-africa/
Thank you Scinv, cant really argue with that - its there in black and white on the NIH/ACTIV-2 clinical protocol site. (ACTIV-2/A5401, FINAL Version 4.0, 2/22/21)
'I think the number recruited is closer to 90 in the UK now but will be really slow as hospitalisation is very slow.I expect they may apply to change the sleeve size.'@ Deal3r, are you able to provide any reference to this patient recruitment figure? any assistance would ben appreciated if so.
This is silly, Scinv has provided the link proving Synairgen was included in this publication last August 2020Open your browser and enter the following link in full (It will show you the original publication naming SNG and shows publication date Aug 20): http://web.archive.org/web/20200831023318/https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.htmlAny discussions stating anything to the contrary are incorrect - FACT!
No worries, :)Agreed it wasn't on the original as far as I'm aware but we were added sometime in late 2020 from memory
@Fruitsneg, yes the NYCT article is what I'm referring to, Interferons have been on that tracker since 2020, I've seen it a few times. Look at the update the article under the interferon section 'Updated March 1', so even the update has been there a little while now (Nearly 2 months).
@Fruitsneg we have actually been on there since last year!
That's good coverage and great to see!